← Canopy Growth Corp
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net loss | ($7.6m) | ($54.1m) | ($670.1m) | — | — | — | — | — | — | — | — | |
| Net Income (Loss) Attributable to Parent | — | — | — | ($1.3b) |
($1.7b)
-32.06%
|
($302.2m)
+82.68%
|
($3.3b)
-984.83%
|
($657.3m)
+79.95%
|
($598.1m)
+9.00%
|
($262.9m)
+56.04%
|
— | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | ($54.1m) | ($670.1m) | ($1.4b) | ($1.7b) | ($320.5m) | ($3.3b) | ($675.8m) | ($598.1m) | ($262.9m) | — | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | ($66.1m) | $74.1m | ($18.3m) | ($31.4m) | — | — | — | — | |
| Depreciation | — | — | — | $73.7m | $70.9m | $76.2m | $56.7m | $28.4m | $21.5m | $19.0m | $19.6m | |
| Amortization of Intangible Assets | $1.9m | $11.8m | $16.9m | $51.3m | $56.2m | $38.2m | $27.8m | $24.8m | $21.6m | $17.4m | — | |
| Depreciation of property, plant and equipment | $4.1m | $8.7m | $30.1m | — | — | — | — | — | — | — | $36.8m | |
| Deferred Income Tax Expense (Benefit) | ($2.7m) | $1.6m | $12.3m | ($138.3m) | ($34.5m) | ($6.6m) | ($667k) | $12.1m | $6.8m | $36k | ($397k) | |
| Share-based Payment Arrangement, Noncash Expense | — | — | — | $320.3m | $91.1m | $47.5m | $31.2m | $14.2m | ($4.2m) | $4.3m | $5.7m | |
| Adjustments For Share-Based Payments | — | $51.2m | $287.8m | — | — | — | — | — | — | — | — | |
| Share-based Payment Arrangement, Expense | — | — | — | $62.2m | $8.1m | — | — | — | — | — | $5.7m | |
| Share-based compensation | $10.0m | $51.2m | $287.8m | — | — | — | — | — | — | — | $5.7m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | $55.2m | — | — | — | — | — | — | — | |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | — | — | — | — | — | ($66.0m) | ($31.2m) | ($67.1m) | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | $40.7m | $1.8b | $42.1m | — | $47.5m | $58.1m | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | — | — | — | — | — | $8.0m | — | |
| Restructuring Costs and Asset Impairment Charges | — | — | — | $623.3m | $534.4m | $369.3m | $2.3b | — | — | $67.1m | — | |
| Income (Loss) from Equity Method Investments | $50k | $1.5m | $10.8m | ($64.4m) | ($52.6m) | ($100k) | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | $224.3m | ($387.9m) | $753.3m | ($466.0m) | ($242.6m) | ($479.9m) | ($101.2m) | — | |
| Share of loss on equity investments | $50k | $1.5m | $10.8m | — | — | — | — | — | — | — | — | |
| Investments in equity method investees | — | ($26.2m) | ($36.9m) | — | — | — | — | — | — | — | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | — | ($21.0m) | $12.0m | ($3.7m) | $9.9m | $3.7m | $4.5m | ($25.7m) | $16.6m | |
| Increase (Decrease) in Inventories | — | — | — | $177.1m | ($17.2m) | ($173.2m) | ($55.6m) | ($1.0m) | $17.7m | ($3.7m) | $4.3m | |
| Inventory Write-down | — | — | — | $169.3m | $79.9m | $237.1m | $82.8m | $9.4m | $10.3m | $17.0m | — | |
| Fair value changes in biological assets included in inventory sold and other charges | $35.0m | $66.3m | $129.5m | — | — | — | — | — | — | — | — | |
| Other assets | — | ($1.9m) | ($19.4m) | — | — | — | — | — | — | — | — | |
| Other liabilities | — | $0 | $54.3m | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | ($27.1m) |
($81.5m)
-200.84%
|
($520.5m)
-538.62%
|
($772.6m)
-48.44%
|
($465.7m)
+39.72%
|
($545.8m)
-17.19%
|
($557.5m)
-2.15%
|
($281.9m)
+49.43%
|
($165.8m)
+41.21%
|
($63.8m)
+61.50%
|
($78.5m)
-23.00%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | ($29.4m) | ($176.0m) | ($644.5m) | $704.9m | $164.5m | $36.7m | $9.2m | $3.4m | $10.8m | $5.3m | ($5.2m) | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $37k | $75k | — | — | — | — | — | — | — | — | — | |
| Purchases of marketable securities | — | ($118k) | ($2.0b) | — | — | — | — | — | — | — | — | |
| Investments in other financial assets | — | ($22.4m) | ($91.3m) | — | — | — | — | — | — | — | — | |
| Payments for (Proceeds from) Other Investing Activities | — | — | — | — | — | $18.1m | ($4.2m) | $7.7m | — | ($7.0m) | — | |
| Net Cash Provided by (Used in) Investing Activities | ($18.6m) | ($223.6m) | ($3.2b) | ($347.7m) | ($884.1m) | $230.8m | $433.4m | $241.6m | ($47.8m) | ($21.3m) | ($21.4m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | — | — | — | $115.0m | $15.6m | $50.8m | $118.2m | $509.8m | $100.0m | $221.5m | ($220.6m) | |
| Proceeds from Issuance of Long-term Debt | $3.5m | — | $600.0m | $14.8m | $893.2m | $0 | $135.2m | — | $68.3m | $208.0m | $208.0m | |
| Repayment of long-term debt | ($959k) | ($1.2m) | ($4.7m) | — | — | — | — | — | — | — | — | |
| Proceeds from Issuance of Common Stock | $130.3m | $470.7m | — | — | — | — | — | — | — | $50.0m | $335.9m | |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | ($3.0m) | ($38.0m) | ($36.3m) | ($24.5m) | ($17.2m) | — | |
| Net Cash Provided by (Used in) Financing Activities | $132.1m |
$525.8m
+298.07%
|
$5.8b
+1010.05%
|
($57.2m)
-100.98%
|
$1.3b
+2312.64%
|
($45.5m)
-103.60%
|
($19.7m)
+56.75%
|
($465.1m)
-2261.40%
|
$148.7m
+131.97%
|
$332.4m
+123.60%
|
$299.5m
-9.91%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $69.6m | ($1.2b) | ($148.5m) | ($378.6m) | ($99.0m) | ($506.7m) | ($56.5m) | $250.9m | $325.8m | |
| Cash and cash equivalents, beginning of period | $101.8m | $322.6m | $2.5b | — | — | — | — | — | — | — | — | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $69.6m | ($204k) | ($63.5m) | ($18.1m) | $44.9m | ($1.3m) | $8.4m | $3.6m | $10.8m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $7.0m | $11.1m | $48.2m | $41.4m | $156.9m | $5.6m | $281k | — | $112k | $0 | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | — | $119.2m | $131.8m | $98.1m | $64.9m | $29.0m | — | |
| Income Taxes Paid, Net | — | — | — | $5.5m | — | — | — | — | — | $144k | — | |
| Additional Financial Items | ||||||||||||
| Adjustments For Decrease Increase In Trade Account Receivable | — | ($15.7m) | ($67.7m) | — | — | — | — | — | — | — | — | |
| Adjustments For Increase Decrease In Trade Account Payable | — | $27.1m | $69.5m | — | — | — | — | — | — | — | — | |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | — | — | — | — | — | $16.1m | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), Realized | — | — | — | ($1.2m) | ($18.0m) | $5.4m | ($8.5m) | $704k | $1.5m | ($624k) | — | |
| General And Administrative Expense | — | $43.8m | $168.4m | — | — | — | — | — | — | — | — | |
| Goodwill | — | $314.9m | $1.5b | $2.0b | $1.9b | $1.9b | $85.6m | $43.2m | $46.0m | $55.7m | $58.1m | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | ($483.7m) | ($604.1m) | ($262.9m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | ($192.1m) | $6.0m | $0 | — | |
| Income Tax Expense (Benefit) | ($2.7m) | $1.6m | $12.3m | ($121.6m) | ($13.1m) | ($8.9m) | ($4.8m) | $12.3m | $7.1m | $23k | — | |
| Increase Decrease In Working Capital | — | $28.5m | $262.2m | — | — | — | — | — | — | — | $5.8m | |
| Interest Paid Classified As Financing Activities | — | — | $14.5m | — | — | — | — | — | — | — | — | |
| Operating Expenses | — | — | — | $1.6b | $1.3b | $889.6m | $2.7b | $309.6m | $196.7m | $231.3m | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | — | $2.1m | $38.3m | — | — | — | — | — | — | — | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | $439.6m | $607.2m | $582.2m | $450.9m | $343.9m | $314.0m | $346.8m | — | |
| Unrealized gain on changes in fair value of biological assets | ($49.1m) | ($100.3m) | ($167.6m) | — | — | — | — | — | — | — | — | |
| Other income and expense | ($5.7m) | ($38.8m) | $75.8m | — | — | — | — | — | — | — | — | |
| Non-cash foreign currency | — | ($201k) | ($18.8m) | — | — | — | — | — | — | — | — | |
| Purchases of intangible assets | ($141k) | ($2.1m) | ($38.3m) | — | — | — | — | — | — | — | — | |
| Net cash outflow on acquisition of subsidiaries | $11.2m | ($3.8m) | ($380.5m) | — | — | — | — | — | — | — | — | |
| Payment of share issue costs | ($8.1m) | ($10.0m) | ($21.6m) | — | — | — | — | — | — | — | — | |
| Proceeds from issuance of common shares and warrants | $130.3m | $470.7m | $5.1b | — | — | — | — | — | — | — | — | |
| Proceeds from issuance of shares by Canopy Rivers | — | $54.9m | $155.0m | — | — | — | — | — | — | — | — | |
| Proceeds from exercise of stock options | $7.0m | $11.1m | $48.2m | — | — | — | — | — | — | — | — | |
| Proceeds from exercise of warrants | $126k | $770k | $18.8m | — | — | — | — | — | — | — | — | |
| Net cash inflow | $86.4m | $220.8m | $2.2b | — | — | — | — | — | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.